As a result of their deliberations committees may make recommendations which they include in their reports for the consideration of the House of Commons or the Government. Recommendations related to this study are listed below.

Recommendation 1

That Veterans Affairs Canada work with the Canadian Institutes of Health Research and all other relevant public and private partners, in Canada and abroad, to establish and fund a series of randomized clinical studies, independent from industry, on the effects of cannabis in treating veterans for the medical conditions they regularly experience and the interaction between cannabinoids and medications regularly prescribed to veterans.

Recommendation 2

That Veterans Affairs Canada, in consultation with Health Canada, consider whether it is appropriate to amend its reimbursement policy on cannabis for medical purposes in order to limit the use of high THC-content cannabis.

Recommendation 3

That Health Canada work with the Canadian Institutes of Health Research, and experts on cannabis from all fields of science, to establish specific guidelines to support physicians who authorize cannabis for medical purposes.

Recommendation 4

That Veterans Affairs Canada implement specific communications for veterans living in rural and remote communities to ensure they have the same access to information about medical cannabis and authorizations for medical cannabis as the rest of the veteran population.

Recommendation 5

That Veterans Affairs Canada work with Health Canada, experts on cannabis from all fields of science, as well as licensed producers, to ensure that the types of cannabis products most likely to be used for medical purposes, including those with high levels of CBD, remain accessible and affordable.

Recommendation 6

That Veterans Affairs Canada work with Health Canada and the Canada Revenue Agency to examine the most appropriate ways of exempting low THC-content products from the excise duty when they are used by veterans for medical purposes.